Chris Newmarker
Executive Editor, Life Sciences at MassDevice
Executive Editor, Life Sciences at Medical Design & Outsourcing
Executive Editor, Life Sciences at Pharmaceutical Processing World
Executive Editor, Life Sciences at Drug Discovery & Development
Executive Editor, Life Sciences at Medical Tubing + Extrusion
A journalist for over 20 years, I am executive editor of Life Sciences at WTWH Media. Media outlets include MassDevice, Medical Design & Outsourcing and more.
Articles
-
2 weeks ago |
massdevice.com | Chris Newmarker
Medtronic (NYSE: MDT) Medtronic plc Open 85.975 Day High 87.049 52 Week High 87.67 52 Week Low 67.11 expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million in its new fiscal year. The world’s largest medtech company, with operational headquarters in Fridley, Minnesota, also announced today that its Diabetes business will become a separate company, preferably through an IPO.
-
2 weeks ago |
medicaldesignandoutsourcing.com | Chris Newmarker
An AdvaMed–Swiss Medtech announcement is just the latest example of AdvaMed’s strategy of working with fellow medtech trade associations at top trade partners to shield the medical device industry from global trade wars. AdvaMed and Swiss Medtech today called for zero-for-zero tariffs and regulatory convergence between the U.S. and Switzerland. The joint statement comes more than a week after a similar announcement from AdvaMed and the Association of British HealthTech Industries.
-
2 weeks ago |
massdevice.com | Chris Newmarker
A federal jury has ordered Johnson & Johnson‘s Biosense Webster business to pay $147 million to a cardiac mapping catheter reprocessor that accused J&J of anticompetitive practices. The Association of Medical Device Reprocessors applauded the May 16 jury decision in favor of Scottsdale, Arizona–based Innovative Health.
-
3 weeks ago |
massdevice.com | Chris Newmarker
AdvaMed CEO Scott Whitaker appeared before the U.S. Senate Finance Committee today to continue to assert that medtech deserves tariff exemptions in trade negotiations. “To be clear, we applaud the president’s efforts to bring more manufacturing back the United States and fix some of the existing trade imbalances, but the reality is, up to 70% of medtech used in America is already made in America, supporting 3 million jobs across this country, and that’s growing every day.
-
3 weeks ago |
massdevice.com | Chris Newmarker
Paragonix Technologies announced today that its LiverGuard System successfully preserved a donor liver transported from the West Coast to a transplant performed at Duke University Hospital in North Carolina. Waltham, Massachusetts–based Paragonix, which Swedish medtech company Getinge acquired for $477 million in 2024, said the case marks one of the longest liver procurements on record, utilizing the company’s advanced hypothermic preservation.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 2K
- Tweets
- 6K
- DMs Open
- No
According to Outset Medical, Inc., the FDA’s warning letter does not request the restriction of Tablo’s manufacturing, production or shipment in the U.S. It also does not request the withdrawal of the system from the U.S. market. S…https://t.co/MLauvwVNZR https://t.co/NJdmv6kHiU
#Medtech #meddevice industry #mergersandacquisitions continue. This time, Coloplast is buying. https://t.co/XgjNYEgaqZ
This move marks the second software-related buy in the past year for ResMed. #medtech #mergersandacquisitions #digitalhealth #sleepapnea #cpap https://t.co/p1UljWrAAL